Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125761402 | 12576140 | 2 | F | 20150311 | 20160729 | 20160720 | 20160804 | EXP | US-ABBVIE-16P-163-1675912-00 | ABBVIE | 55.83 | YR | F | Y | 73.55000 | KG | 20160804 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125761402 | 12576140 | 1 | PS | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | Oral | 1057294 | 21168 | 500 | MG | BID | |||||||
| 125761402 | 12576140 | 2 | C | BRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125761402 | 12576140 | 3 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 0 | 10 | MG | ||||||||||
| 125761402 | 12576140 | 4 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 125761402 | 12576140 | 5 | C | BIOTIN | BIOTIN | 1 | 0 | 300 | UG | ||||||||||
| 125761402 | 12576140 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | 1 | MG | ||||||||||
| 125761402 | 12576140 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 125761402 | 12576140 | 8 | C | CODEINE PHOSPHATE W/GUAIFENESIN | 2 | 10-100MG | 0 | ||||||||||||
| 125761402 | 12576140 | 9 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125761402 | 12576140 | 1 | Idiopathic generalised epilepsy |
| 125761402 | 12576140 | 2 | Product used for unknown indication |
| 125761402 | 12576140 | 3 | Product used for unknown indication |
| 125761402 | 12576140 | 4 | Product used for unknown indication |
| 125761402 | 12576140 | 5 | Product used for unknown indication |
| 125761402 | 12576140 | 6 | Insomnia |
| 125761402 | 12576140 | 7 | Product used for unknown indication |
| 125761402 | 12576140 | 8 | Product used for unknown indication |
| 125761402 | 12576140 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125761402 | 12576140 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125761402 | 12576140 | Anxiety | |
| 125761402 | 12576140 | Fall | |
| 125761402 | 12576140 | Head injury | |
| 125761402 | 12576140 | Headache | |
| 125761402 | 12576140 | Ligament sprain | |
| 125761402 | 12576140 | Myoclonic epilepsy | |
| 125761402 | 12576140 | Tremor | |
| 125761402 | 12576140 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125761402 | 12576140 | 1 | 20140403 | 0 |